University of Queensland researchers have announced a new tool in the fight against cancer, with the development of a world-first test that will direct treatment choices for patients with some forms of blood cancer.
University of Queensland Diamantina Institute researcher Dr Liliana Endo-Munoz has identified two proteins that play a pivotal role in enabling bone cancer tumours to spread throughout the body.
New research from Children’s Health Queensland, UQ Diamantina Institute and Cancer Council shows survival rates are on the rise for a dangerous yet rare form of childhood cancer.
Every year in Australia, more than 4000 people are diagnosed with Head and Neck Squamous Cell Carcinoma (HNSCC). In more than half of these patients, the disease is already advanced and their prognosis is poor.
New treatments are on the horizon for ankylosing spondylitis and two other debilitating conditions that affect up to three per cent of the global population – thanks to a research and development deal involving University of Queensland research.
University of Queensland researchers have developed a world-first vaccine-style therapeutic approach to treat rheumatoid arthritis, a debilitating disease affecting more than 450,000 people in Australia.
Dr Andrew Brooks is part of an international team of scientists who have determined that unstructured parts of Class 1 cytokine receptors are able to interact with the inner membrane of cells.
